Skip to main content
Clinical Trials/CTRI/2023/04/051266
CTRI/2023/04/051266
Not yet recruiting
Phase 2

A single arm clinical study to evaluate the efficacy add on effect of Ajmodadi vati in the managment of Prameha with special reference to Diabetis mellitus Type2

Bhagwan Kakasaheb Muley0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Sponsor
Bhagwan Kakasaheb Muley
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Bhagwan Kakasaheb Muley

Eligibility Criteria

Inclusion Criteria

  • Patient with fasting blood sugar \>126mg/dl upto 200mg/dl and post prandial blood sugar \>200mg/dl upto 450mg/dl

Exclusion Criteria

  • Diabetes mellitus type 2 Acromegaly cushings syndrome and pancreatic disorders
  • Pregnant and lactating mothers
  • Patients with known case of Diabetic nephropathy and retinopathy
  • Patients with gastrointestinal disease liver disease and tumors cardiovascular disease acute myocardial infarction DKA hyperosmolar non ketotic diabetic coma

Outcomes

Primary Outcomes

Not specified

Similar Trials